
Andrea Sikora, PharmD, MSCR, FCCM, FCCP, BCCCP, led a 21-member panel on critical care pharmacists and joined us to discuss how guideline updates may impact the greater pharmacy industry.

Andrea Sikora, PharmD, MSCR, FCCM, FCCP, BCCCP, led a 21-member panel on critical care pharmacists and joined us to discuss how guideline updates may impact the greater pharmacy industry.

After experiencing tragedy in his personal life, Bil Schmidtknecht was led to join the community of independent pharmacists and industry advocates calling for PBM reform across both aisles.

From the perspective of someone directly impacted by PBM practices, Bil Schmidtknecht shares his insights into the ways PBMs affect patients’ access to medications.

After sharing his son’s tragic story, Bil Schmidtknecht discusses the common ways the Big 3 PBMs operate and how smaller organizations are on the rise, becoming unlikely competitors.

Bil Schmidtknecht joined Drug Topics to share his son’s tragic story and how it motivated him to join the greater fight in putting the lives of patients at the forefront of health care.

Addressing the impacts on patients and the overall pharmacy market, Joey Mattingly, PharmD, MBA, PhD, discusses trends in pharmacies opening and closing across the country.

In part 3 of our interview with Joey Mattingly, PharmD, MBA, PhD, he discusses potential government policies for reducing pharmacy closures.

While experts have been measuring the impacts stemming from US pharmacy deserts, they are also working to establish a path forward to reduce closures and increase access.

Ryan Bingham, chief operating officer at iA, discusses how his team is advancing technology within the pharmacy to help locations around the country drive efficiency.

With a myriad of non-traditional pharmacy roles on the rise, Ashley Kay Pendrick, PharmD, owner of Prosper Rx Consulting, provided insights into the opportunities at hand for US pharmacists.

Ashley Kay Pendrick, PharmD, owner of Prosper Rx Consulting, provided insights on how pharmacists can expand their scope within the confines of current practice regulations.

As a clinical pharmacy consultant with more than a decade of experience, Ashley Kay Pendrick, PharmD, shared her insights into non-traditional pharmacy roles.

Through her work with Prosper Rx Consulting, Ashley Kay Pendrick, PharmD, discusses the expansion of pharmacists’ roles beyond medication dispensing.

As researchers continue to measure the impacts of the COVID-19 pandemic on public health, Hashim Zaibak, PharmD, discusses the evolution of community pharmacies in a postpandemic world.

From Scripts to Screens: AAP’s Ginny Langbehn Shares Winning Digital Strategies for Independent Pharmacies

When independent and retail storefronts close across the country, creating a lack of pharmacy services in the community, pharmacy deserts arise.

With expertise into the growing issue of pharmacy deserts, Michael Murphy, PharmD, MBA, discussed exactly what patients are losing when their community no longer has pharmacy access.

Michael Murphy, PharmD, MBA, joined Drug Topics to present his ideas for correcting the growing issue of pharmacy deserts and unprecedented closures across the country.

Kristen Jones, PharmD, discusses leadership strategies in pharmacy management that prioritize emotional intelligence and communication for enhanced team performance and patient care.

Pharmacy professionals evolve into strategic leaders, mastering emotional intelligence and management skills to navigate complex workplace dynamics and enhance patient care.

Kristen Jones, PharmD, discusses challenging traditional workplace paradigms by emphasizing the human element in pharmaceutical operations.

Kristen Jones, PharmD, discusses pharmacists as leaders at McKesson ideaShare 2025.

Michael Murphy, PharmD, MBA, provided insights on his research regarding pharmacy deserts, who they impact the most, and the methods needed to improve them in the US.

Brooklyn Morgan, PharmD, discusses the transformation of pharmacy practice from a regulatory model to a more flexible approach.

Thomas Sherrer, PharmD, emphasizes teamwork and technology in inventory management to enhance patient safety and reduce medication errors.

Thomas Sherrer, PharmD, advocates for a team-driven, tech-enhanced approach to pharmacy inventory management, boosting patient care and operational efficiency.

Brooklyn Morgan, PharmD, director of state policy at the National Alliance of State Pharmacy Associations, emphasizes the importance of making the pharmacist's voice heard.

Congressman Buddy Carter (R-GA) champions the PBM Reform Act of 2025, aiming to enhance drug price transparency and empower pharmacists in healthcare delivery.

Thomas Sherrer, PharmD, co-owner of Poole's Pharmacy, describes implementing multiple tracking methods to stay ahead of drug shortages.

Crystal Lennartz, president of Health Mart & Health Mart Atlas at McKesson, discusses challenges that independent pharmacies are facing in today's health care landscape.
Please check back later for more content.




